Document is current
Any future updates will be listed below
-
Authors
Fu, Weijun
Bang, Soo-Mee
Huang, Honghui
Kim, Kihyun
Li, Wei
An, Gang
Lee, Je-Jung
Cai, Zhen
Jin, Jie
Wang, Yafei
Chim, Chor Sang
Carson, Robin
Liu, Rui
Zhao, Man
Chen, Xi
Cui, Canchan
Hou, Jian
Wang, Jianxiang
-
Funding
Funding for this research was provided by:
Johnson & Johnson
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 4 March 2025
First Online: 23 May 2025
Declarations
:
: The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki, Good Clinical Practices, and abided by all applicable regulatory requirements. The study protocol and amendments were reviewed and approved by Independent Ethics Committees and Institutional Review Boards at each participating site, and all patients provided written informed consent.
: R.C., R.L., X.C., and C.C. are employees of Johnson & Johnson and own stock or stock options. M.Z. is an employee of IQVIA, which was contracted by Johnson & Johnson for the presented analyses. J.W. served as a member of the board of directors or advisory committees at AbbVie. All other authors have nothing to declare.
